Asp Isotopes Inc. (ASPI) Stock Price & Analysis
Asp Isotopes Inc. (ASPI) fell 0.48% to USD 4.18 as of September 8, 2026 at 18:39 UTC, according to Nexqual real-time market data.
ASPI last closed at USD 4.2; the session ranged USD 4.18–4.41 on volume of 3,066,032 shares. Market capitalization is $640.83M, with a 52-week range of USD 3.51–14.49 (NCM). Source: Nexqual, September 8, 2026 at 18:39 UTC.
Key Statistics (as of September 8, 2026 at 18:39 UTC)
| Price | USD 4.18 |
|---|---|
| Change | ▼ 0.48% (down) |
| Previous Close | USD 4.2 |
| Open | USD 4.29 |
| Day Range | USD 4.18 – 4.41 |
| 52-Week Range | USD 3.51 – 14.49 |
| Volume | 3,066,032 shares |
| Market Cap | $640.83M |
| Exchange | NCM |
Technical Analysis (ASPI)
Nexqual's technical model rates ASPI "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of September 8, 2026 at 18:39 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.05 (neutral) |
| vs SMA50 | Below (USD 4.35) |
| MACD | -0.1 (negative) |
Analyst Ratings (ASPI)
Wall Street analysts rate ASPI "None" based on 3 analysts, with a mean price target of USD 13 (range USD 11–15), per Nexqual as of September 8, 2026 at 18:39 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 13 |
| High Target | USD 15 |
| Low Target | USD 11 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (ASPI)
| Next Earnings Date | 2026-11-12 |
|---|---|
| EPS Estimate | USD -0.13 |
| Revenue Estimate | $4.83M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.25 vs est -0.39 ▲ beat |
| 2026-03-31 | USD -0.05 vs est -0.28 ▲ beat |
| 2025-12-31 | USD -0.41 vs est -0.14 ▼ miss |
| 2025-09-30 | USD -0.15 vs est -0.1 ▼ miss |
Source: Nexqual, September 8, 2026 at 18:39 UTC.
Financials & Fundamentals (ASPI)
| Total Revenue | $30.85M |
|---|---|
| Revenue Growth (YoY) | +327.60% |
| Gross Margin | +18.32% |
| Operating Margin | -667.48% |
| Profit Margin | +0.00% |
| ROE | -90.35% |
| Debt / Equity | 98.09 |
| Current Ratio | 3.87 |
| Total Cash | $254.90M |
| Total Debt | $269.54M |
| Free Cash Flow | $-28.59M |
Source: Nexqual, September 8, 2026 at 18:39 UTC.
Financial Health Score (ASPI)
Nexqual rates Asp Isotopes Inc.'s overall financial health "Weak" across five dimensions, as of September 8, 2026 at 18:39 UTC.
| Growth | Strong — Revenue +475% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $255M cash vs $270M debt |
| Cash Flow | Weak — FCF negative: -$29M, burning cash |
| Efficiency | Critical — ROE -90%, ROA -17.0% |
Ownership (ASPI)
| Insider Ownership | +10.50% |
|---|---|
| Institutional Ownership | +48.08% |
| Shares Outstanding | 153.31M |
| Float | 133.02M |
| Short % of Float | +19.09% |
Source: Nexqual, September 8, 2026 at 18:39 UTC.
Leadership (ASPI)
Asp Isotopes Inc. is led by Paul Elliot Mann C.F.A. (age 49), Executive Chairman & CEO, per Nexqual as of September 8, 2026 at 18:39 UTC.
| Executive Chairman & CEO | Paul Elliot Mann C.F.A. (age 49) |
|---|---|
| Chief Financial Officer | Heather Kiessling (age 60) |
| Chief Operating Officer | Robert Ainscow (age 48) |
| Co-Chief Operating Officer | Nicholas Michael Mitchell (age 45) |
| Chief Technology Officer | Hendrik Strydom B. Sc, M. Sc (age 64) |
Major Backers & Investors (ASPI)
Notable institutional backers of Asp Isotopes Inc. include Encompass Capital Advisors, LLC, Exchange Traded Concepts LLC, Rovida Investment Management Ltd, according to Nexqual as of September 8, 2026 at 18:39 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Encompass Capital Advisors, LLC | 4.28% |
| Exchange Traded Concepts LLC | 2.95% |
| Rovida Investment Management Ltd | 2.67% |
| UBS Group AG | 2.12% |
| Alyeska Investment Group, L.p. | 1.85% |
| Fidelity | 1.19% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.58% |
| Vanguard Group | 6.79% |
| Geode Capital | 1.92% |
| State Street | 1.69% |
Source: Nexqual, September 8, 2026 at 18:39 UTC.
From Asp Isotopes Inc.'s Latest SEC 10-K Filing (filed 2026-04-10)
Key Strengths & Strategy (as disclosed to the SEC)
- Our proprietary enrichment technologies, the Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment technology ("QE technology"), are designed to enable the production of isotopes for a range of industrial and advanced technology applications.
- We plan to begin research and development for the enrichment of uranium to demonstrate our capability to produce HALEU using QE technology.
- We believe we compare favorably with many of our helium competitors due our geographic location near the Cape of Good Hope, which we believe will allow us to provide helium to parts of the world that other competitors, such as companies located in Qatar, cannot.
Partnerships
- On March 29, 2026, QLE entered into a securities exchange agreement with an investor (the "QLE Exchange Agreement").
- Agreements with TerraPower LLC On April 4, 2024, we entered into an agreement with TerraPower to develop a conceptual design, refined cost/schedule/financing, risk register, and term sheet for a HALEU facility (the "TerraPower Agreement").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LTBR | Lightbridge Corporation | USD 7.99 | ▲ 6.82% |
| NNE | Nano Nuclear Energy Inc. | USD 19.4 | ▲ 9.89% |
| LEU | Centrus Energy Corp. | USD 190.12 | ▲ 11.53% |
| LAES | SEALSQ Corp | USD 2.47 | ▲ 2.92% |
| EU | enCore Energy Corp. | USD 1.26 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 18:39 UTC. This page is informational and not investment advice.